Reiko Matsui

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Hiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu et al. · International Journal of Clinical Oncology · 2019 · 145 citations · Full text

Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study

K. Suzuki, Takeharu Yamanaka, Hiroki Hashimoto et al. · Annals of Oncology · 2016 · 97 citations · Full text

Oncology, Metronomic Therapy, Pharmacology +6

Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial

Daiki Tsuji, Kenichi Suzuki, Yohei Kawasaki et al. · Supportive Care in Cancer · 2018 · 37 citations

Oncology, Cisplatin-based Chemotherapy, Chemotherapy-induced Nausea +6

Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia

Mashiro Okunaka, Daisuke Kano, Reiko Matsui et al. · Pharmaceuticals · 2021 · 30 citations · Full text

Epidemiology Of Cancer, Pathology, Pharmacotherapy +21

Partial Cancer Prevalence in Japan up to 2020: Estimates Based on Incidence and Survival Data from Population-based Cancer Registries

Nobuyuki Tabata, Yuko Ohno, Reiko Matsui et al. · Japanese Journal of Clinical Oncology · 2008 · 20 citations · Full text